Corporate Membership

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single service or a synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept and beyond.

Biomere is a global, nonclinical CRO with locations on the east and west coast, and in China (JOINN). Our personal approach and drive to expedite research timelines, make us ideally suited to support our clients’ needs.

Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. We work together globally and with integrity.

Charles River has a global network of scientific experts offering robust safety assessments of drugs, devices, and chemicals. Experience with all molecules types and regulations to mitigate risk for development.

Expect More: more attention, insight and a superlative experience. Inotiv delivers a comprehensive and integrated range of right-size in vivo discovery and tox services, BioA, pathology, DMPK and consulting solutions essential to your success.

Lovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.

Lilly unites caring with discovery to create medicines that make life better for people around the world.

Noble Life Sciences is a preclinical CRO with decades of experience in drug, vaccine, and device development. GLP and non-GLP services, PK/PD, safety, toxicology, and cell-based assays with a strong focus on oncology and infectious diseases.

Hope changes lives. We’re in relentless pursuit of scientific breakthroughs and revolutionary medicines that will create a healthier world for everyone.

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.